- Home
- SSY vs THAR Comparison
SSY vs THAR Comparison
Compare SSY & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- THAR
- Stock Information
- Founded
- SSY 1959
- THAR 2017
- Country
- SSY United States
- THAR United States
- Employees
- SSY N/A
- THAR N/A
- Industry
- SSY Hospital/Nursing Management
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- THAR Health Care
- Exchange
- SSY Nasdaq
- THAR Nasdaq
- Market Cap
- SSY 6.2M
- THAR 5.5M
- IPO Year
- SSY N/A
- THAR 2022
- Fundamental
- Price
- SSY $0.97
- THAR $1.78
- Analyst Decision
- SSY
- THAR Strong Buy
- Analyst Count
- SSY 0
- THAR 1
- Target Price
- SSY N/A
- THAR $17.00
- AVG Volume (30 Days)
- SSY 88.5K
- THAR 41.3K
- Earning Date
- SSY 05-13-2025
- THAR 08-08-2025
- Dividend Yield
- SSY N/A
- THAR N/A
- EPS Growth
- SSY N/A
- THAR N/A
- EPS
- SSY 0.25
- THAR N/A
- Revenue
- SSY $31,094,000.00
- THAR N/A
- Revenue This Year
- SSY N/A
- THAR N/A
- Revenue Next Year
- SSY N/A
- THAR N/A
- P/E Ratio
- SSY $4.08
- THAR N/A
- Revenue Growth
- SSY N/A
- THAR N/A
- 52 Week Low
- SSY $0.62
- THAR $0.95
- 52 Week High
- SSY $1.91
- THAR $6.39
- Technical
- Relative Strength Index (RSI)
- SSY 54.43
- THAR 57.46
- Support Level
- SSY $0.87
- THAR $1.60
- Resistance Level
- SSY $1.10
- THAR $1.88
- Average True Range (ATR)
- SSY 0.07
- THAR 0.15
- MACD
- SSY 0.01
- THAR 0.01
- Stochastic Oscillator
- SSY 50.65
- THAR 71.21
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.